As of 2026-05-30, the Relative Valuation of Pulmonx Corp (LUNG) is (25.45) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.65 USD, the upside of Pulmonx Corp based on Relative Valuation is -1642.2%.
The range of the Relative Valuation is (21.44) - (26.38) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.9x - 20.9x | 19.5x |
| Forward P/E multiples | 17.0x - 21.9x | 20.9x |
| Fair Price | (21.44) - (26.38) | (25.45) |
| Upside | -1399.4% - -1698.7% | -1642.2% |
| Date | P/E |
| 2026-05-29 | -1.31 |
| 2026-05-28 | -1.33 |
| 2026-05-27 | -1.22 |
| 2026-05-26 | -1.25 |
| 2026-05-22 | -1.23 |
| 2026-05-21 | -1.22 |
| 2026-05-20 | -1.22 |
| 2026-05-19 | -1.06 |
| 2026-05-18 | -1.04 |
| 2026-05-15 | -1.01 |
| 2026-05-14 | -1.06 |
| 2026-05-13 | -1.06 |
| 2026-05-12 | -1.02 |
| 2026-05-11 | -1.03 |
| 2026-05-08 | -1.00 |
| 2026-05-07 | -1.01 |
| 2026-05-06 | -1.02 |
| 2026-05-05 | -1.01 |
| 2026-05-04 | -1.06 |
| 2026-05-01 | -1.07 |
| 2026-04-30 | -1.02 |
| 2026-04-29 | -0.95 |
| 2026-04-28 | -0.98 |
| 2026-04-27 | -1.02 |
| 2026-04-24 | -1.01 |
| 2026-04-23 | -1.02 |
| 2026-04-22 | -1.03 |
| 2026-04-21 | -1.06 |
| 2026-04-20 | -1.13 |
| 2026-04-17 | -1.17 |
| 2026-04-16 | -1.16 |
| 2026-04-15 | -1.19 |
| 2026-04-14 | -1.13 |
| 2026-04-13 | -1.14 |
| 2026-04-10 | -1.09 |
| 2026-04-09 | -1.08 |
| 2026-04-08 | -1.02 |
| 2026-04-07 | -1.02 |
| 2026-04-06 | -1.08 |
| 2026-04-02 | -1.06 |
| 2026-04-01 | -1.02 |
| 2026-03-31 | -1.02 |
| 2026-03-30 | -0.94 |
| 2026-03-27 | -0.93 |
| 2026-03-26 | -0.98 |
| 2026-03-25 | -1.03 |
| 2026-03-24 | -1.04 |
| 2026-03-23 | -1.10 |
| 2026-03-20 | -1.08 |
| 2026-03-19 | -1.10 |